Thought Leadership

  • KOL Identification & Mapping

    By: Miriam EllisJuly 21, 2022

    The Relationship Between KOL Identification And KOL Mapping

    Among the infinite symposia, webinars, and white papers on this topic, “KOL identification” and “KOL mapping” can find themselves melting together in a gelatinous jargon stew. 

    Read more
  • KOL Research

    By: Miriam EllisJuly 21, 2022

    Studies On Adaptive Trials In Rare Cancer

    Rare cancers account for up to 20% of new cancer cases and Innovative Medicinal Products (InMP) are required to address this high unmet medical need. Adaptive trials may be an alternative to large randomized controlled trials for InMP development to target rare cancer patients.

    Read more
  • KOL Identification

    By: Miriam EllisJuly 21, 2022

    Unfeasibly Prolific Authors

    Using publication history from PubMed to help identify Experts or assess an individual KOLs work?

    Read more